Mahkam Zanganeh - 15 Dec 2021 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Operating Officer, Director
Signature
/s/ Maky Zanganeh
Issuer symbol
SMMT
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 15:16:45 UTC
Previous filing
21 May 2021
Next filing
23 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +15,000 15,000 15 Dec 2021 Common Stock 15,000 $4.75 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) The option was granted on December 15, 2021. The shares underlying the option are scheduled to vest on December 15, 2024 (the three-year anniversary of the grant date).
F2 (2) Not applicable.